"Don't worry about the world coming to an end today. It's already tomorrow in Australia"

Liked By
Spread the love. Be the first to like this post!
Recent BHVN News
- Current Report Filing (8-k) • Edgar (US Regulatory) • 05/31/2023 11:04:49 AM
- Biohaven Provides Overview of Clinical Progress, Regulatory Updates, and Pipeline Developments at R&D Day • PR Newswire (US) • 05/31/2023 11:00:00 AM
- Biohaven to Present R&D Day at Yale School of Management • PR Newswire (US) • 05/25/2023 09:00:00 PM
- Securities Registration: Employee Benefit Plan (s-8) • Edgar (US Regulatory) • 05/12/2023 08:43:35 PM
- Biohaven Reports First Quarter 2023 Financial Results and Reports Recent Business Developments • PR Newswire (US) • 05/12/2023 08:30:00 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/04/2023 09:53:20 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/04/2023 09:53:16 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/04/2023 09:53:10 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/04/2023 09:52:44 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/04/2023 09:52:25 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/04/2023 09:52:14 PM
- Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 05/04/2023 09:52:02 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 05/04/2023 09:18:12 PM
- Biohaven Expands Executive Leadership Team with Appointment of Nick Kozauer M.D. as Senior Vice President for Clinical Development and Regulatory Strategy • PR Newswire (US) • 04/17/2023 11:00:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/24/2023 10:04:03 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 03/23/2023 08:37:15 PM
- Annual Report (10-k) • Edgar (US Regulatory) • 03/23/2023 08:24:26 PM
- Biohaven Reports Fourth Quarter and Full Year 2022 Financial Results and Reports Recent Business Developments • PR Newswire (US) • 03/23/2023 08:05:00 PM
- Amended Statement of Changes in Beneficial Ownership (4/a) • Edgar (US Regulatory) • 03/22/2023 10:08:34 PM
- Biohaven Acquires Exclusive License for Oral, Brain-Penetrant, Dual TYK2/JAK1 Inhibitor for Immune-Mediated Brain Disorders • PR Newswire (US) • 03/22/2023 11:30:00 AM
- Biohaven Announces Presentation at the American Society for Experimental Neurotherapeutics (ASENT) Annual Meeting • PR Newswire (US) • 03/14/2023 11:30:00 AM
- Biohaven Gets FDA Fast-Track Tag for Taldefgrobep in Spinal Muscular Atrophy • Dow Jones News • 02/21/2023 01:16:00 PM
- Biohaven's Taldefgrobep Alfa Receives FDA Fast Track Designation for Spinal Muscular Atrophy • PR Newswire (US) • 02/21/2023 12:30:00 PM
- Amended Statement of Ownership (sc 13g/a) • Edgar (US Regulatory) • 02/13/2023 06:32:47 PM
- Statement of Ownership (sc 13g) • Edgar (US Regulatory) • 02/13/2023 05:50:35 PM
Swifty Global Announces Acquisition of Business-to-Business Contracts and Technology from GLNetworks Ltd in Five Countries • DRCR • Jun 5, 2023 10:14 AM
ILUS International Inc (ILUS) Sees 557% Q1 Revenue Increase, Begins National Exchange Uplist Procedure for Subsidiaries and Company • CNNA • Jun 5, 2023 8:15 AM
Game Time Productions to be Featured on 3 Major Television Networks • GRNL • Jun 1, 2023 9:59 AM
New Break Announces Closing of $500,700 Non-Brokered Flow-Through Financing • NBRK • Jun 1, 2023 7:35 AM
Alarum Recorded First-Ever Positive Cashflow from Operating Activities with Record Revenues in the First Quarter of 2023 • ALAR • May 30, 2023 10:02 AM
MindBio Therapeutics CEO Demonstrates how 1 Million Microdoses of LSD can Potentially be Used to Treat Depression at Scale • MBIO • May 30, 2023 8:00 AM